Sackett D, Rosenberg WM, Gray JA, Haynes RB, Richardson WS: Evidence based medicine: What it is and what it isn't. BMJ. 1996, 312: 71-72. 10.1136/bmj.312.7023.71.
Lorenz K, Ryan G, Morton S, Chan K, Wang S, Shekelle P: A qualitative examination of primary care providers' and physicians managers' uses and views of research evidence. International Journal for Quality in Health Care. 2005, 17: 409-414. 10.1093/intqhc/mzi054.
Guyatt G, Cook D, Haynes B: Evidence based medicine has come a long way. BMJ. 2004, 329: 900-901.
Claridge J, Fabian T: History and Development of evidence-based medicine. World Journal of Surgery. 2005, 29: 547-553. 10.1007/s00268-005-7910-1.
McAlister F, O'Connor A, Wells G, Grover S, Laupacis A: When should hypertension be treated? The different perspectives of Canadian family physicians and patients. CMAJ. 2000, 163: 403-408.
Cabana M, Rand C, Powe N, Wu A, Wilson M, Abboud PA, Rubin H: Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999, 282: 1458-1465. 10.1001/jama.282.15.1458.
Grol R, Grimshaw J: From best evidence to best practice: effective implementation of changes in patients' care. Lancet. 2003, 362: 1225-1230. 10.1016/S0140-6736(03)14546-1.
Houghton A, Cowley A: Why are angiotension converting enzyme inhibitors underutilized in the treatment of heart failure by general practitioners?. Int J Cardiol. 1997, 59: 7-10. 10.1016/S0167-5273(96)02904-X.
Jacobson N, Berns S, McGilinchey J: Methods for defining and interpreting the cinical significance of treatment effects: Description, application, and alternatives. J Consult Clin Psychol. 1999, 67: 300-307.
Tunis S, Stryer D, Clancy C: Practical clinical trials. Increasing the value of clinical research for decision making in clinical and health policy. JAMA. 2003, 290: 1624-1632. 10.1001/jama.290.12.1624.
Crosby R, Kolotkin R, Williams R: Defining clinically meaningful change in health-related quality of life. Journal of Clinical Epidemiology. 2003, 56: 395-407. 10.1016/S0895-4356(03)00044-1.
Scales DC, Rubenfeld GD: Estimating sample size in critical care clinical trials. J Crit Care. 2005, 20 (1): 6-11. 10.1016/j.jcrc.2005.02.002.
Copay AG, Subach BR, Glassman SD, Polly DW, Schuler TC: Understanding the minimum clinically important difference: a review of concepts and methods. Spine J. 2007, 7 (5): 541-546. 10.1016/j.spinee.2007.01.008.
Barrett B, Brown D, Mundt M, Brown R: Sufficiently important difference: expanding the framework of clinical significance. Med Decis Making. 2005, 25: 250-261. 10.1177/0272989X05276863.
Morgan C: Sample size re-estimation in group-sequential response-adaptive clinical trials. Stat Med. 2003, 22: 3843-3857. 10.1002/sim.1677.
Jaeschke R, Singer J, Guyatt G: Measurement of health status: ascertaining the minimal clinically important difference. Control Clin Trials. 1989, 10: 407-415. 10.1016/0197-2456(89)90005-6.
Hays R, Woolley J: The concept of clinically important differences in health-related quality of life research. Pharmoeconomics. 2000, 18: 419-423. 10.2165/00019053-200018050-00001.
Beaton D, Boers M, Wells G: Many faces of the minimal clinically important difference (MCID): A literature review and directions for future research. Curr Opin Rheumatol. 2002, 14: 109-114. 10.1097/00002281-200203000-00006.
Kashani I, Hall JL, Hall JC: Reporting of minimum clinically important differences in surgical trials. ANZ J Surg. 2009, 79 (4): 301-304. 10.1111/j.1445-2197.2009.04865.x.
Wolfe F, Michaud K, Strand V: Expanding the definition of clinical differences: from minimally clinically important differences to really important differences. Analyses in 8931 patients with rheumatoid arthritis. J Rheumatol. 2005, 32 (4): 583-589.
Naylor CD, Llewellyn-Thomas HA: Can there be a more patient-centred approach to determining clinically important effect sizes for randomized treatment trials?. J Clin Epidemiol. 1994, 47 (7): 787-795. 10.1016/0895-4356(94)90176-7.
Make B: How can we assess outcomes of clinical trials: the MCID approach. COPD: Journal of Chronic Obstructive Pulmonary Disease. 2007, 4: 191-194. 10.1080/15412550701471231.
Kirkby HM, Wilson S, Calvert M, Draper H: Using e-mail recruitment and an online questionnaire to establish effect size: A worked example. BMC Med Res Methodol. 2011, 11 (1): 89-10.1186/1471-2288-11-89.
Brasher PM, Brant RF: Sample size calculations in randomized trials: common pitfalls. Can J Anaesth. 2007, 54 (2): 103-106. 10.1007/BF03022005.
van Walraven C, Mahon J, Moher D, Bohm C, Laupacis A: Surveying physicians to determine the minimally important difference: Implications for sample-size calculation. J Clin Epidemiol. 1999, 52: 717-723. 10.1016/S0895-4356(99)00050-5.
Kirwan JR: Minimum clinically important difference: the crock of gold at the end of the rainbow?. J Rheumatol. 2001, 28: 439-444.
Wood S, Ross S, Sauve R, Brant R: Vaginal progesterone versus placebo in multiple pregnancy. ClinicalTrials.gov http://clinicaltrials.gov/ct2/show/NCT00343265 (accessed 13 June 2011)
McGowan J, Alderdice F, Holmes V, Johnston L: Early childhood development of late-preterm infants: a systematic review. Pediatrics. 2011, 127: 1111-1124. 10.1542/peds.2010-2257.
Ross S: Composite outcomes in randomized clinical trials: arguments for and against. Am J Obstet Gynecol. 2007, 196 (2): 119-e1-6
Kramer MS, Demissie K, Yang H, Platt RW, Sauve R, Liston R: The contribution of mild and moderate preterm birth to infant mortality. Fetal and Infant Health Study Group of the Canadian Perinatal Surveillance System. JAMA. 2000, 284 (7): 843-849. 10.1001/jama.284.7.843.
Clements KM, Barfield WD, Ayadi MF, Wilber N: Preterm birth-associated cost of early intervention services: an analysis by gestational age. Pediatrics. 2007, 119 (4): e866-10.1542/peds.2006-1729. 74.32
Hassan S, Romero R, Vidyadhari D, Fusey S, Baxter J, Khandelwal M, Vijayaraghavan J, Trivedi Y, Soma-Pillay P, Sambarey P, Dayal A, Potapov V, O'Brien J, Astakhov V, Yuzko O, Kinzler W, Dattel B, Sehdev H, Mazheika L, Manchulenko D, Gervasi MT, Sullivan L, Conde-Agudelo A, Phillips JA, Creasy GW: PREGNANT Trial. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol. 2011, 38: 18-31.
Berghella V, Rafael T, Szychowski J, Rust O, Owen J: Cerclage for short cervix on ultrasonography in women with singleton gestations and previous preterm birth: a meta-analysis. Obstet Gynecol. 2011, 117: 663-671. 10.1097/AOG.0b013e31820ca847.
Rode L, Klein K, Nicolaides KH, Krampl-Bettelheim E, Tabor A: PREDICT Group. Prevention of preterm delivery in twin gestations (PREDICT): a multicenter, randomized, placebo-controlled trial on the effect of vaginal micronized progesterone. Ultrasound Obstet Gynecol. 2011, 38: 272-280.
Stock S, Norman J: Preterm and term labour in multiple pregnancies. Semin Fetal Neonatal Med. 2010, 15: 336-341. 10.1016/j.siny.2010.06.006.
van Os M, van der Ven J, Kleinrouweler E, Pajkrt E, de Miranda E, van Wassenaer A, Porath M, Bossuyt PM, Bloemenkamp KW, Willekes C, Woiski M, Oudijk MA, Bilardo KM, Sikkema MJ, Duvekot JJ, Veersema D, Laudy J, Kuiper P, de Groot CJ, Mol BW, Haak MC: Preventing preterm birth with progesterone: costs and effects of screening low risk women with a singleton pregnancy for short cervical length, the Triple P study. BMC Pregnancy Childbirth. 2011, 11: 77-10.1186/1471-2393-11-77.
Pramod R, Okun N, McKay D, Kiehn L, Hewson S, Ross S, Hannah ME: Cerclage for the short cervix demonstrated by transvaginal ultrasound: current practice and opinion. J Obstet Gynaecol Can. 2004, 26 (6): 564-570.
Arunkalaivanan AS, Barrington JW: Questionnaire-based survey on obstetricians and gynaecologists' attitudes towards the surgical management of urinary incontinence in women during their childbearing years. Eur J Obstet Gynecol Reprod Biol. 2003, 108 (1): 85-93. 10.1016/S0301-2115(02)00431-1.